triamcinolone acetonide

(redirected from Azmacort HFA)
Also found in: Wikipedia.

triamcinolone acetonide

; Adcortyl corticosteroid preparation (10mg/mL) for intrasynovial, intra-articular or soft-tissue injection

triamcinolone acetonide (topical) (as´ətō´nīd),

n brand names: Aristocort, Flutex, Kenalog, Kenalog in Orabase, Oracort, Triacet, Triderm, others;
drug class: topical corticosteroid;
action: interacts with steroid cytoplasmic receptors to induce antiinflammatory effects; possesses antipruritic and antiinflammatory actions;
uses: treatment of psoriasis, eczema, contact dermatitis, pruritus; special dental paste used to treat nonviral inflammatory oral lesions, including aphthous stomatitis, lichen planus, and cicatrical pemphigoid.
References in periodicals archive ?
Additionally, upon the launch of an Azmacort HFA formulation (HFA, or hydrofluoralkane propellant, has significantly less ozone-depleting potential than the propellant in the original Azmacort formulation), Kos will pay Aventis an annual royalty on net sales.
The Company plans to maintain its research and development focus, increasing product development investments 35% - 40% from 2004, excluding the effect of the one-time, $38 million in-process R&D write-off associated with purchase of Azmacort HFA.
08 Impact of One-Time Events Azmacort HFA acquisition: -In-process R&D (38,000) (0.